Lung diseases
Conditions
Interventions
None listed
Sponsors
National Hospital Organization Nagoya Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with lung lesions on chest CT, to whom tissue sampling by cryobiopsy is considered adequate for a pathological diagnosis. 2. >=20 years old 3. Patients who can temporarily interrupt anticoagulant/antiplatelet agents 4. Informed consent
Exclusion criteria
Exclusion criteria: 1. Lesion located within the inner second ellipse from the hilum on chest CT 2. Patients who were previously enrolled in this trial 3. Patients who need to undergo a bronchoscopic procedure for a nontarget lesion in the same setting 4. Patients with large lung cysts near the biopsy site 5. Lesions near a large vessel 6. Lesions inaccessible to the cryoprobe (e.g. apical lung lesions) 7. Patients with a diffuse lung disease who are receiving steroid therapy 8. Pregnant woman 9. Bleeding tendency 10. Pulmonary hypertension 11. Serious concomitant medical illness 12. Other clinical difficulties
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Safety (frequency of bleeding) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Safety (frequency of complications other than bleeding) 2. Pathological diagnostic yield 3. Procedural duration 4. Frequency of oxygen desaturation 5. Size of specimens | — |
Countries
Japan
Contacts
Public ContactMasahide Oki
National Hospital Organization Nagoya Medical Center Department of Respiratory Medicine
Outcome results
None listed